CAR T-Cell Therapy | Radiation & Immunotherapy | Lung Cancer Study, 02/14/2024

National Cancer Institute

Having trouble viewing this email? View it as a Web page.

Bookmark and Share

Cancer Information Highlights
From the National Cancer Institute
Updating you about cancer causes, prevention, screening, treatment, coping, and more
New from NCI
India’s First Homegrown CAR T-Cell Therapy Has Roots in NCI Collaboration
Young child sits on adult's lap while health care provider listens with a stethoscope   Training provided by NCI scientists helped researchers in India design an effective CAR T-cell therapy, NexCAR19. This new treatment can be made in India, sold at a reasonable cost, and meet the needs of patients in India’s health care system.

Read More
Manipulating an Immune Cell May Make Radiation Therapy More Effective
A bolt of radiation boost levels of the BAMBI protein in an immune cell.   In a study in mice, researchers showed they could enhance radiation therapy by boosting levels of a protein called BAMBI in certain immune cells found in and around tumors.

Read More

The ALCHEMIST Lung Cancer Trials

ALCHEMIST is a group of randomized clinical trials for people with early-stage non-small cell lung cancer whose tumors have been removed by surgery. These trials test whether adding targeted therapy based on the genetics of a person’s tumor will help prevent the cancer from returning.

Read More

Chemotherapy and You: Support for People with Cancer

This publication for people with cancer explains chemotherapy, side effects you may have, ways to manage these side effects, and tips for talking with your doctor and nurse. It is available as a PDF.

Read More

Contact Us
cancer information specialist   Information specialists at NCI’s Cancer Information Service (CIS), NCI's contact center, are available to help answer your cancer-related questions in English and Spanish. This page tells you how to reach us by phone, chat, or email.